While reporting financial results for the fourth quarter on Tuesday, medical devices maker Medtronic plc. (MDT) reiterated its adjusted earnings and organic revenue growth guidance for the full-year 2025.
For fiscal 2025, the company now projects adjusted earnings in a range of $5.44 to $5.50 per share on revenue growth of 3.4 to 3.8 percent, with organic revenue growth of 4.75 to 5.0 percent.
On average, analysts polled expect the company to report earnings of $5.45 per share on revenue growth of 3.71 percent to $33.57 billion for the year. Analysts' estimates typically exclude special items.
"Looking ahead, our restored earnings power continues. We will accelerate both top and bottom line growth in Q4, resulting in high-single digit adjusted EPS growth in the back half of our fiscal year," said Gary Corona, Medtronic interim chief financial officer.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback: editorial@rttnews.com